A Molecular Key to Unlocking Keloid Pathology and Surgical Scarring
Recent research published in The American Journal of Pathology has identified a novel signaling pathway critical to keloid formation, a challenging complication in wound healing and reconstructive surgery. The study utilized single-cell RNA sequencing to analyze keloid and normal skin samples, revealing that the interaction between SEMA3C and its receptor PLXND1 drives excessive collagen production in keloid fibroblasts. This fibrotic process is mediated through the well-known TGF-β1 signaling pathway. Experimental validation showed that blocking this interaction with PLXND1-specific siRNA or inhibiting TGF-β1 significantly reduced collagen metabolism, pinpointing a potential therapeutic target for preventing abnormal scar formation after surgical procedures.
Study Significance: For surgeons specializing in plastic, reconstructive, or any procedure where optimal wound healing is paramount, this research moves beyond describing keloids to defining a specific molecular mechanism. Identifying the SEMA3C/PLXND1 axis offers a precise target for future perioperative interventions, such as topical or injectable agents, to modulate scar formation. This could transform postoperative care protocols, reducing the need for revision surgery and improving cosmetic and functional outcomes for patients across surgical oncology, trauma surgery, and elective procedures.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
